The 135-year-old global health care conglomerate sells everything from Band-Aids and artificial hips to surgical robots, cancer drugs, and one of America’s first three authorized COVID vaccines. The pandemic affected many of those businesses, and J&J’s sales overall were relatively flat last year—notching up 0.6%. While the company’s pharmaceutical division performed well, results were mixed for the consumer segment: Sales of over-the-counter products like Tylenol surged, while baby care and women’s health revenues plummeted. Likewise, the company’s medical devices business recorded a sales decline of 11.6%, largely owing to people delaying procedures during the pandemic.
Lists ranking Johnson & Johnson
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list
Latest news for Johnson & Johnson